Mycosubtilin

Mycosubtilin: sourced facts only. name: "SPR analysis supported direct, reversible binding of Myco to immobilized p38α under the tested in vitro conditions." [PMID:42731185]; target: "SPR analysis supported direct, reversible binding of Myco to immobilized p38α under the tested in vitro conditions." [PMID:42731185]; developer: "Xinjiang Key Laboratory of Special Species Conservation and Regulatory Biology, College of Life Science, Xinjiang Normal University, Urumqi, China." [PMID:42731185]; modality: "mycosubtilin (Myco), a Bacillus subtilis-derived cyclic lipopeptide" [PMID:42731185]; stage: "Myco significantly suppressed HepG2 proliferation in a dose- and time-dependent manner and inhibited xenograft tumor growth, with preliminary tolerability indicated by stable body weight and histopathological examination of selected organs." [PMID:42731185]